The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/datopotamab-deruxtecan-earns-new-breast-cancer-indication-2026a1000gti?src=rss
Author :
Publish date : 2026-05-22 17:45:00
Copyright for syndicated content belongs to the linked Source.
